Related Experiment Video
Updated: Jan 4, 2026
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Decoy oligodeoxynucleotide technology: an emerging paradigm for breast cancer treatment
Maryam Mahjoubin Tehran1, Samaneh Rezaei1, Amin Jalili1
1Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Breast cancer is the most common cancer in women worldwide. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, which is resistant to conventional therapies. Therefore, there is an urgent need to identify new therapies for treating incurable breast cancer in patients. Decoy oligodeoxynucleotides (ODNs) are synthetic oligonucleotides that have a high affinity for a specific transcription factor and can be transfected into target cells to bind to their respective target and alter gene transcription. With these powerful tools available, it is highly possible to effectively regulate the expression of genes that are involved in the pathogenesis of breast cancer. Here, we highlight the studies using decoy ODNs for the development of novel therapies against breast cancer.
Insights
New decoy oligodeoxynucleotides (ODNs) offer a promising strategy for treating aggressive triple-negative breast cancer (TNBC). These synthetic molecules can regulate gene expression, providing a novel therapeutic approach for this challenging disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a global health concern, with triple-negative breast cancer (TNBC) representing an aggressive subtype resistant to standard treatments.
- The lack of effective therapies for TNBC necessitates the exploration of novel treatment strategies.
Purpose of the Study:
- To review the application of decoy oligodeoxynucleotides (ODNs) in developing innovative therapies for breast cancer.
- To highlight the potential of decoy ODNs in targeting gene expression pathways crucial to breast cancer pathogenesis.
Main Methods:
- Decoy ODNs are synthetic oligonucleotides designed to bind specific transcription factors.
- These ODNs can be introduced into cells to modulate the transcription of target genes involved in disease.
- The review focuses on studies investigating the use of decoy ODNs against breast cancer.
Main Results:
- Decoy ODNs demonstrate a high affinity for transcription factors, enabling targeted gene regulation.
- This targeted approach offers a potential method to control gene expression implicated in breast cancer development.
- The studies reviewed suggest decoy ODNs as a viable tool for novel breast cancer therapeutics.
Conclusions:
- Decoy ODNs represent a promising platform for developing targeted therapies against breast cancer, particularly TNBC.
- Further research into decoy ODN technology could lead to effective treatments for patients with limited options.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
